Ann: RGI Signs Heads of Agreement with Amfil Technologies, page-14

Following on from my previous post. Canadian Bioceutical Corp (BCC) 1st did a deal with Rotogro International Lim (RIL) 2 years ago in June 2015. They ordered 60 units subject to finance which also gave them 1st right of refusal to acquire the units in Canada. https://finance.yahoo.com/news/canadian-bioceutical-corporation-roto-gro-130000977.html

Looking at the accounts of RIL and RWW (rotogro worldwide) for May 27 2015 to June 30 2016, there was no revenue, so I suspect the deal fell thru or was deferred.

RIL was incorporated in May 2015 just prior to the agreement with BCC. Capital was raised with seed shares in the 12 months following the agreement. There was a change in MD in Aug '16 when Michael Carli took over. The previous MD was a specialist in monetizing private equity investments in micro cap companies.

The reason I bring up this history is because I have a strong feeling the EuroAg deal is for BCC.
- BCC is leasing the units, so sale would be to the leasor
- BCC is still planning to use the RGI units, as per the presentations in my last post
- same initial order for 60 units, whole order 240 EuroAg, 250 initial BCC agreement
- BCC initial agreement & EuroAg agreement both have exclusivity rights, though different.
- RIL, RWW & RGI have had no sales income since the deal.

On the BCC website http://canadianbioceutical.com/ you can download the latest presidents letter, dated 2 weeks ago.
You can see they have recently acquired quite a few companies, seem to be expanding rapidly. Some of these companies are already producing, however under "Next steps" they say:

"we will focus on asset development ......as well as implementing, at these various new locations, the best practices ........introducing innovative growing and extraction technologies (such as Roto-Grow) "

Talking about their new Arizona facility they say:
"we also have the space and ability to double our Arizona cultivation capacity to 3.2 million grams per annum. At this location, we expect to deploy an innovative growing technology in the form of Roto-Grow, a low footprint, low-cost, high-yielding technology, which we anticipate will bring production costs to, or below, the US$1 per gram mark. "